NVP-AAK-980

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameNVP-AAK-980

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtein-tyrosine kinases inhibitorsSRC inhibitors

TargetsProtein-tyrosine kinasesSRC

Therapy Area/IndicationsOsteoporosis, Postmenopausal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSwitzerland

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsOsteoporosis, Postmenopausal

ATC CodeN/A